humanitarian Archived signal Translated · Русский · 2–5m lag

Доклад об оценке состояния окружающей среды в Европе: Stekeyma, metekinumab, дата получения разрешения: 22/08/2024, пересмотренный вариант: 10, статус: санкционировано

Доклад об оценке состояния здоровья населения Европы: Зумрад, Сасанлимб, Состояние: заявление отозвано

Reported by EMA What Is New
Read the complete report at EMA What Is New
Verification notice

IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.

INCIDENT FUSION

12 reports · 2 sources

EMA What Is NewДоклад об оценке состояния окружающей среды в Европе: Stekeyma, metekinumab, дата получения разрешения: 22/08/2024, пересмотренный вариант: 10, статус: санкционированоEMA What Is NewДоклад об оценке состояния окружающей среды в Европе: Stekeyma, metekinumab, дата получения разрешения: 22/08/2024, пересмотренный вариант: 10, статус: санкционированоEMA What Is NewHuman medicines European public assessment report (EPAR): Avtozma, tocilizumab, Date of authorisation: 14/02/2025, Revision: 8, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Avtozma, tocilizumab, Date of authorisation: 14/02/2025, Revision: 8, Status: AuthorisedEMA What Is NewДоклад об оценке состояния здоровья населения Европы (EPAR): Sepalna, senaparib, State: OpinionEMA What Is NewHuman medicines European public assessment report (EPAR): Ruxolitinib Zentiva, ruxolitinib, Status: OpinionEMA What Is NewHuman medicines European public assessment report (EPAR): Povofortay, povorcitinib, Status: OpinionEMA What Is NewHuman medicines European public assessment report (EPAR): Zeydovio, glepaglutide, Status: OpinionEMA What Is NewHuman medicines European public assessment report (EPAR): Adcomfo, omalizumab, Status: OpinionEMA What Is NewHuman medicines European public assessment report (EPAR): Lifyorli, relacorilant, Status: OpinionEMA What Is NewHuman medicines European public assessment report (EPAR): Inijaq, tofacitinib, Status: OpinionEMA What Is NewHuman medicines European public assessment report (EPAR): Frehemgo, denecimig, Status: Opinion
INCIDENT EVOLUTION

8 recorded states

Signal first indexedP2 · 99% quality · 2 sources

Headline updatedP2 · 99% quality · 2 sources

Source details updatedP2 · 99% quality · 2 sources

Source details updatedP2 · 99% quality · 2 sources

Source details updatedP2 · 99% quality · 2 sources

Source details updatedP2 · 99% quality · 2 sources

Source details updatedP2 · 99% quality · 2 sources

Source details updatedP2 · 99% quality · 2 sources

Explore this day in the archive →
QUALITY CONTROL

Report this signal

Reports are anonymous and retained privately for editorial review.